Vifant Overview

  • Founded
  • 2015

  • Status
  • Private

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $225K

  • Investors
  • 2

Vifant General Information


Developer of a mobile application designed to identify vision impairment in verbal, non-verbal and pre-verbal patients. The company's application uses the established principle of optico-kinetic nystagmus which is the eyes' reflexive, spontaneous response to moving patterns that does not need to be instructed or learned, enabling users to detect of vision problems early in a cost-effective way.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Outcome Management (Healthcare)
Other Industries
Application Software
Primary Office
  • 3401 Grays Ferry Avenue
  • Philadelphia, PA 19146
  • United States
+1 (215) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vifant Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Grant 01-Jan-2018 $225K Completed Startup
1. Accelerator/Incubator 01-Sep-2015 Completed Startup
To view Vifant’s complete valuation and funding history, request access »

Vifant Executive Team (3)

Name Title Board Seat Contact Info
Beth DeSouza Chief Executive Officer
Monte Mills Founder
You’re viewing 2 of 3 executive team members. Get the full list »

Vifant Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Small Business Innovation Research and Small Business Technology Transfer Programs Government Minority 000 0000 000000 0
UPstart (Philadelphia) Accelerator/Incubator Minority 000 0000 000000 0
To view Vifant’s complete investors history, request access »